Alphabet-Owned Firm to Begin Human Trials for AI-Developed Cancer Drug
Isomorphic Labs, a pharmaceutical company owned by Alphabet, is preparing to begin human trials for its cancer drug, developed using AlphaFold 3, an advanced AI...
Tag : Isomorphic Labs
Isomorphic Labs Secures $600 Million in Funding
Isomorphic Labs, an AI-driven drug discovery startup, has raised $600 million in its first-ever external funding round, led by Thrive Capital, the company announced on...